Science & Health
1 回表示
FDA gives full approval to lecanemab for early Alzheimer’s after trial showed slower decline
The U.S. Food and Drug Administration has granted full approval to lecanemab, a treatment for early-stage Alzheimer’s disease that was shown in late-stage trials to slow cognitive decline. The…
2時間前